Ibere Pharmaceuticals Total Assets

Ibere Pharmaceuticals (IBER) currently reports a total assets of $140M as of September 2022. That compares with $140M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Ibere Pharmaceuticals's total assets history and peer comparisons.

Ibere Pharmaceuticals's total assets was unchanged from $140M to $140M — essentially flat versus a year earlier (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ibere Pharmaceuticals reported $140M in total assets as of September 2022. That compares with $140M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ibere Pharmaceuticals, and consider following IBER for alerts when major investors trade the stock.